Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects

Detalles Bibliográficos
Autores principales: Tiberti, Claudio, Nenna, Raffaella, Tromba, Valeria, Filardi, Tiziana, Petrarca, Laura, Silvestri, Francesca, Fassino, Valeria, Montuori, Monica, Mancino, Enrica, Lenzi, Andrea, Midulla, Fabio, Costantino, Francesco, Morano, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442254/
https://www.ncbi.nlm.nih.gov/pubmed/37474814
http://dx.doi.org/10.1007/s00592-023-02152-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442254/
https://www.ncbi.nlm.nih.gov/pubmed/37474814
http://dx.doi.org/10.1007/s00592-023-02152-6

Ejemplares similares